Stay updated with breaking news from Guardant Infinity. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
New research demonstrates value of epigenomic analysis and methylation sequencing with Guardant liquid biopsy portfolio across continuum of cancer care New data show strong performance of...
COSMOS study shows Guardant Reveal™ blood test highly predictive for disease recurrence in patients with early-stage colon cancer without need for tissue specimen ...
The oncology diagnostic companies are looking for better solutions in early cancer diagnosis.
New research further confirms value of interrogating epigenomic signals with Guardant Infinity™ platform to identify novel biomarker targets and predict treatment resistance ... | May 31, 2023
Guardant Health, Inc. (NASDAQ:NASDAQ:GH) Q3 2022 Earnings Conference Call November 03, 2022 04:30 PM ET Company Participants Alex Kleban - Vice President, Investor Relations Helmy Eltoukhy...